02.12.2016 Views

Journal Thoracic Oncology

WCLC2016-Abstract-Book_vF-WEB_revNov17-1

WCLC2016-Abstract-Book_vF-WEB_revNov17-1

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Abstracts <strong>Journal</strong> of <strong>Thoracic</strong> <strong>Oncology</strong> • Volume 12 Issue S1 January 2017<br />

surgically treated octogenarians compared to younger patients. Methods:<br />

The institutional database of all consecutive patients treated between 2009<br />

and 2015 was analysed. The age cut-off was set at 80 years. Perioperative<br />

and follow-up data were compared between the two groups. Results: A total<br />

of 453 patients were treated by a VATS approach at our center for proven<br />

NSCLC. 28 (6.2%) patients were aged 80 or older. There was no difference in<br />

gender distribution, clinical T stage, preoperative FEV1/FVC and preoperative<br />

haemoglobin values. Clinical N stage was higher in the octogenarians<br />

(p=0.049). Median operative time was 175 minutes in the younger patients<br />

compared to 156 minutes in the octogenarians (p=0.104). Neither tumor<br />

diameter nor distribution of tumor histology showed any significant<br />

difference between the two groups. Postoperative haemoglobin values as<br />

a surrogate parameter for intraoperative complications were comparable<br />

between the groups. Median hospital stay was 10 days in both groups<br />

(p=0.634). There was no in-hospital mortality in the octogenarians. Disease<br />

free (72.1 vs. 58.4 months, p=0.673) and overall survival (81.7 vs. 83.8 months,<br />

p=0.456) did not show any significant difference between octogenarians and<br />

younger patients.<br />

or over have been increasing in the aging society, which are accounted for<br />

approximately 10% in Japan. Due to the prolonged life expectancy in the<br />

elderly, it is inevitable to assess the feasibility of pulmonary resection for<br />

lung cancer especially in patients over 85 years in age. Methods: From 1995<br />

to 2015, we underwent 3,099 pulmonary resections for lung cancers in our<br />

department. Among them, 213 (6.8%) were aged 80 years or older. They were<br />

divided into 2 groups based on the age, i.e., “Over80” who were aged from 80<br />

to 84 and “Over85” who were aged 85 or elder. Clinicopathological factors<br />

were analyzed between these two groups, using the t-test or the Chi-squared<br />

test. Survivals were calculated by Kaplan-Meier estimation methods. Results:<br />

Of the cases, 174 (84%) showed Over80 and 39 (18%) showed Over85. The<br />

proportions for male, comorbidity rate, c-stage I disease in the Over85 group<br />

were not significantly different than those of the Over80 group (age; 20 (51%)<br />

vs. 105 (60%), p=0.189: comorbidity; 36 (92%) vs. 154 (89%), p=0.489: c-stage I;<br />

36 (92%) vs. 143 (82%), p=0.119). The surgical candidates of the octogenarian<br />

included 167 (78%) radiological pure-solid lung cancer, however, there was<br />

not significant difference between the 2 groups (28 (72%) vs. 139 (80%),<br />

p=0.267). Lobectomy was equally performed in 28 (72%) on the Over85 and<br />

126 (72%) of the Over80 (p=0.938), respectively. Perioperative morbidities<br />

were observed in 104 (48%) of the patients, though, significant difference<br />

was not found between the two study arms (84 (48%) vs. 20 (51%), p=0.734)<br />

and the 30-day mortality rates was observed just one patient for the Over80<br />

group. The 5-year overall survival was 51.1% in the Over80 group, 62.6% in<br />

the Over85 group (p=0.275), respectively. Conclusion: In the octogenarians,<br />

a patient with radiological pure-solid lung cancer was more common as a<br />

surgical candidate for the definitive local management. Although proper<br />

patient selection and meticulous perioperative management were mandatory<br />

for surgical resection of the very elderly, our results support the finding that<br />

radical surgical intervention could be feasible even for the patients with high<br />

age over 85 years.<br />

Keywords: Pulmonary resections for lung cancer in patients aged 80 years or<br />

over<br />

POSTER SESSION 1 - P1.08: SURGERY<br />

RISK ASSESSMENT & PROGNOSTIC FACTORS –<br />

MONDAY, DECEMBER 5, 2016<br />

P1.08-012 CHARACTERIZING TIME TO CARE FOR LUNG CANCER<br />

SURGICAL PATIENTS<br />

Breanne Cadham 1 , Janine Olsen 2 , Rasika Rajapakshe 2 , Michael Humer 3<br />

1 BC Cancer Agency, Kelowna/Canada, 2 BC Cancer Agency, Kelowna/BC/Canada,<br />

3 Kelowna <strong>Thoracic</strong> Surgical Group, Kelowna/BC/Canada<br />

Conclusion: Lung resection can safely be performed in selected octogenarians<br />

with acceptable morbidity and low mortality rates. In our experience it is even<br />

as safe as in younger patients. Our data adds evidence that in such patients<br />

potentially curative treatment should not be withheld.<br />

Keywords: octogenarians, VATS<br />

POSTER SESSION 1 - P1.08: SURGERY<br />

RISK ASSESSMENT & PROGNOSTIC FACTORS –<br />

MONDAY, DECEMBER 5, 2016<br />

P1.08-011 FEASIBILITY OF SURGICAL RESECTION FOR LUNG<br />

CANCER PATIENTS AGED OVER 85 YEARS<br />

Takehiro Ouchi, Aritoshi Hattori, Takeshi Takeshi Matsunaga, Kazuya<br />

Takamochi, Shiaki Oh, Kenji Suzuki<br />

General <strong>Thoracic</strong> Surgery, Juntendo University, Tokyo/Japan<br />

Background: The Kelowna <strong>Thoracic</strong> Surgical Group (KTSG), centered in<br />

Kelowna, British Columbia (BC), Canada provides care to a geographic area of<br />

807,538 km 2 . This is 85% of the province of BC and approximately 9 times the<br />

size of Austria. A significant portion of this population consists of remote and<br />

rural communities. Ensuring equal and prompt access to lung cancer diagnosis<br />

and treatment regardless of proximity to treatment center is important not<br />

only because of the time sensitivity of care, but also because of the overall<br />

healthcare burden of this highly prevalent and often lethal malignancy.<br />

Methods: A retrospective chart review was performed on all patients seen<br />

by the KTSG who came to definitive surgical treatment in Kelowna for a<br />

diagnosed or suspected lung cancer between January 2010 and December<br />

2015. Dates were collected at three time-points along the care pathway:<br />

Referral, Consult, and Surgical Treatment. We calculated times from referral<br />

to consult (RC), consult to treatment (CT), and overall referral to treatment<br />

(RT). Demographic information was collected for each of the patients and<br />

the distances patients’ lived from the Surgical Centre were determined. The<br />

study has received approval from both University of British Columbia – BC<br />

Cancer Agency and Interior Health Authority research ethics boards. Results:<br />

There were 902 patients in the cohort; 446 local patients who lived within a<br />

radius of 100 km or less from Kelowna and 456 distant patients who resided<br />

further than 100 km from the city. For the entire group, the median RT was<br />

50.5 days comprised of RC = 6 days, and CT = 42 days. For the local patient<br />

group, the median RT was 49 (Interquartile Range (IQR) = 33.75 to 69) days<br />

compared to a median of 52.5 (IQR = 36 to 52.5) days for the distant patients.<br />

The extreme overlap in the IQR shows no significant clinical difference in time<br />

to care between the local and distant patients. Conclusion: Time from referral<br />

to treatment for patients with suspected or confirmed lung cancer seen by<br />

the IHTSG is similar for both local and distant patients. The equitable times<br />

to care with the IHTSG suggests that the current model of patient-doctor<br />

communication provides a growing opportunity to mitigate the impact of<br />

distance on access to care.<br />

Keywords: Health Equity, <strong>Thoracic</strong> Surgery, Time to Care<br />

Background: Pulmonary resections for lung cancer in patients aged 80 years<br />

Copyright © 2016 by the International Association for the Study of Lung Cancer<br />

S381

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!